Lymphadenopathy diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
Revision as of 22:35, 29 July 2020
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy diagnostic criteria On the Web |
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria |
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Diagnostic Criteria
Malignant Lymphadenopathy
- Node > 2 cm
- Node that is draining, hard, or fixed to underlying tissue
- Atypical location (e.g. supraclavicular node)
- Risk factors (e.g. HIV or TB)
- Fever and/or weight loss
- Splenomegaly
Benign Lymphadenopathy
- Node < 1 cm
- Node that is mobile, soft-or tender, and is not fixed to underlying tissue
- Common location (e.g. supraclavicular node)
- No associated risk factors
- Palpable and painful enlargement